A Review of Randomized Controlled Trials of Hereditary Angioedema Long-Term Prophylaxis with C1 Inhibitor Replacement Therapy: Alleviation of Disease Symptoms Is Achievable

Through its fluctuating disease activity and unpredictable attacks, hereditary angioedema (HAE) imposes a substantial patient burden. To minimize HAE burden and improve quality of life, treatment should involve individualized management strategies that address on-demand therapy and short-term/long-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Longhurst, Hilary J, Valerieva, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010185/
https://www.ncbi.nlm.nih.gov/pubmed/36922963
http://dx.doi.org/10.2147/JAA.S396338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010185/
https://www.ncbi.nlm.nih.gov/pubmed/36922963
http://dx.doi.org/10.2147/JAA.S396338

Ejemplares similares